SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-024168
Filing Date
2020-05-11
Accepted
2020-05-11 16:06:48
Documents
70
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q nk-10q_20200331.htm 10-Q 2386678
2 EX-10.1 nk-ex101_98.htm EX-10.1 24206
3 EX-31.1 nk-ex311_7.htm EX-31.1 19705
4 EX-31.2 nk-ex312_6.htm EX-31.2 19698
5 EX-32.1 nk-ex321_9.htm EX-32.1 7336
6 EX-32.2 nk-ex322_8.htm EX-32.2 7296
7 GRAPHIC gsa2an1ajaqd000001.jpg GRAPHIC 60785
  Complete submission text file 0001564590-20-024168.txt   8330172

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT nk-20200331.xml EX-101.INS 1810154
9 XBRL TAXONOMY EXTENSION SCHEMA nk-20200331.xsd EX-101.SCH 54159
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nk-20200331_cal.xml EX-101.CAL 58897
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nk-20200331_def.xml EX-101.DEF 184643
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE nk-20200331_lab.xml EX-101.LAB 441144
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nk-20200331_pre.xml EX-101.PRE 344792
Mailing Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121
Business Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121 (858) 633-0300
NantKwest, Inc. (Filer) CIK: 0001326110 (see all company filings)

IRS No.: 431979754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37507 | Film No.: 20864794
SIC: 2836 Biological Products, (No Diagnostic Substances)